Pharmaceutical firm Eli Lilly agreed on Tuesday to provide $5m of equity and research funding to Entrega, a US-based affiliate of biopharmaceutical company PureTech Health, as part of a research collaboration agreement. Entrega is developing an oral peptide delivery technology that will replace injections as a method of administering drugs.
Japan-based online advertising optimisation technology developer Kaizen Platform raised $4.6m in series C funding on Wednesday from YJ Capital, Dentsu Innovation Partners, SBI Investment and Mizuho Capital, respective subsidiaries of…
